Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiviral drug
nucleoside analog reverse transcriptase inhibitor |
| gptkbp:alsoKnownAs |
gptkb:ddC
gptkb:dideoxycytidine |
| gptkbp:approvalYear |
1992
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:J05AF03
|
| gptkbp:CASNumber |
gptkb:7481-89-2
|
| gptkbp:developedBy |
gptkb:Hoffmann-La_Roche
|
| gptkbp:discontinued |
gptkb:United_States
2006 |
| gptkbp:drugClass |
gptkb:NRTI
|
| gptkbp:hasMolecularFormula |
C9H13N3O3
|
| https://www.w3.org/2000/01/rdf-schema#label |
zalcitabine
|
| gptkbp:legalStatus |
discontinued
|
| gptkbp:mechanismOfAction |
inhibits HIV reverse transcriptase
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
pancreatitis
peripheral neuropathy oral ulcers |
| gptkbp:usedFor |
HIV infection
|
| gptkbp:bfsParent |
gptkb:NRTIs
|
| gptkbp:bfsLayer |
5
|